Edition:
United States

People: Sarepta Therapeutics Inc (SRPT.O)

SRPT.O on Nasdaq

93.61USD
23 Aug 2019
Change (% chg)

$-1.46 (-1.54%)
Prev Close
$95.07
Open
$94.53
Day's High
$96.49
Day's Low
$92.98
Volume
1,801,284
Avg. Vol
1,363,841
52-wk High
$165.87
52-wk Low
$90.24

Cumbo, Alexander 

Mr. Alexander Cumbo is Executive Vice President and Chief Commercial Officer of the Company. Mr. Cumbo has served as our Executive Vice President, Chief Commercial Officer since February 2019. Prior to this appointment, he served as our Senior Vice President, Chief Commercial Officer from May 2017 to February 2019, Senior Vice President of Global Commercial Organization from October 2016 to May 2017, Vice President, Global Commercial Development from September 2015 to September 2016 and Vice President, Global Business and Commercial Development from January 2013 to August 2015. From June 2010 to January 2013, Mr. Cumbo worked at Vertex Pharmaceuticals Inc., a biopharmaceutical company, where he served as Vice President of Sales and Treatment Education for the launch of Incivek. Prior to working at Vertex, Mr. Cumbo worked for Gilead Sciences, a biopharmaceutical company, for nine years in multiple commercial roles supporting the HIV, HBV and Cardiovascular franchises. Mr. Cumbo started his career at GlaxoSmithKline plc and has over twenty years of pharmaceutical and biotechnology experience. Mr. Cumbo holds a Bachelor of Science (B.S.) in Medical Technology from Auburn University.

Basic Compensation

Total Annual Compensation, USD 689,776
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,425,380
Fiscal Year Total, USD 3,115,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 36,282 4,324,990.00
Name Fiscal Year Total

M. Kathleen Behrens

502,152

Douglas Ingram

1,433,870

Sandesh Mahatme

4,219,080

David Howton

3,129,380

Alexander Cumbo

3,115,160

Gilmore O'Neill

6,449,180
As Of  30 Dec 2018